April 3, 2026

Science Chronicle

A Science and Technology Blog

April 3, 2026

Science Chronicle

A Science and Technology Blog

Month: November 2020

Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccines

Oxford vaccine shows 90% efficacy in Phase-3 trial

Two doses of the vaccine given in two different regimen showed different efficacies. In the case of the regimen (involving

Read More
Clinical trialCoronavirusEthicsPublic HealthSARS-CoV-2Vaccines

Ethics of denying COVID-19 vaccine to placebo group participants once EUA is granted

Offering the vaccine right away to those in the placebo group will first require unblinding the study. Unblinding the study and offering the vaccine to the placebo group will make it almost impossible to gather further information on vaccine efficacy, thus making full licensure challenging.

Read More
Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccines

Oxford vaccine found safe and immunogenic even in older adults

The results were published online in The Lancet on November 19. The results are based on the study of 560

Read More
Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccines

Pfizer’s mRNA vaccine 95% efficacious, final analysis shows

On November 18, Pfizer announced that the final efficacy analysis of its candidate mRNA-based vaccine (BNT162b2) in phase-3 trial has

Read More
Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccines

More mRNA COVID-19 vaccines show stability at higher temperatures

The interim results of Moderna’s mRNA vaccine show that the vaccine has 94.5% efficacy in preventing COVID-19. The interim analysis,

Read More
Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccines

Pfizer’s COVID-19 vaccine shows promise, many unknowns remain

The results of the Phase-1 trial, announced in August, first through a press release and then through a preprint a

Read More
CoronavirusDrugsHealthPharmaceutical companiesPublic HealthSARS-CoV-2

Eight Indian generic drug companies join international coalition, pledge to make COVID-19 drugs

The companies have come together under the umbrella of the non-profit Medicines Patent Pool (MPP). Indian companies that have pledged

Read More
CoronavirusPublic HealthSARS-CoV-2Vaccines

It makes sense to bring people to the vaccine instead of taking COVID-19 vaccine to people in some settings: Gagandeep Kang

The government recently said it will procure the vaccine and distribute it under a special COVID-19 immunisation programme to certain

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2World Health Organisation

No evidence to suggest cluster 5 variant increases coronavirus transmissibility, disease severity

So far, six countries — Denmark, the Netherlands, Spain, Sweden, Italy and the U.S. — have reported SARS-CoV-2 in farmed

Read More